Last reviewed: June 20, 2026

Last updated: June 20, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide works as a glucagon-like peptide-1 receptor agonist that signals fullness and slows digestion, making it one of the most effective medications for sustainable weight management available today. The medication comes in the form of a once-weekly subcutaneous injection, meaning you administer it yourself under the skin on the same day each week. Understanding your injection schedule and how dosing progression works is essential for maximizing results while maintaining consistency with your treatment plan.

Weekly Injection Schedule: Timing and Consistency

Semaglutide injections are designed as a once-per-week medication, giving you a simple dosing routine that fits easily into weekly wellness habits. Most patients choose the same day and time each week—such as Sunday morning or Monday evening—to establish a predictable rhythm and reduce the chance of missed doses. Consistency matters because maintaining steady medication levels in your system supports appetite suppression and metabolic benefits more effectively than sporadic dosing.

You can adjust your injection day by a few days if needed for personal scheduling, but staying within a consistent weekly window helps your body respond optimally to the treatment. The subcutaneous injection takes only seconds and can be given in the abdomen, upper arm, or thigh using a pre-filled pen or syringe. Many patients find that setting a phone reminder on their chosen injection day eliminates the guesswork and keeps them accountable to their weight management plan.

Dose Escalation: Starting Low and Advancing Gradually

Semaglutide dosing follows a structured escalation protocol that typically spans 16 to 20 weeks, beginning at 0.25 mg and advancing through intermediate steps before reaching higher maintenance doses. This gradual approach minimizes gastrointestinal side effects like nausea and allows your body to adapt to the medication's appetite-suppressing effects without overwhelming your system. Your starting dose depends on your current health status, prior GLP-1 exposure, and tolerance profile, which is why PlexusDx recommends discussing your baseline with your prescribing provider.

Each dose increase occurs at roughly four-week intervals, giving your body adequate time to respond and stabilize before advancing further. Skipping doses or advancing too quickly can increase nausea, vomiting, or constipation, while a conservative pace typically results in better long-term adherence and outcomes. PlexusDx's flat monthly pricing model—starting at $149 per month—means your investment remains the same regardless of which step you're on during your dose escalation, eliminating financial barriers to reaching your therapeutic dose.

Managing Side Effects During the Injection Schedule

Nausea is the most commonly reported side effect during the first few weeks of semaglutide therapy, particularly when doses increase, but symptoms typically improve within days to weeks as your body adjusts. Eating smaller, lighter meals with lower fat content, staying hydrated, and taking injections in the evening can help reduce nausea intensity. Most patients find that gentle movement after meals and avoiding strong food odors during the adjustment period further supports comfort and compliance with their weekly injection routine.

Constipation and mild fatigue may also occur during dose escalation, but these effects generally resolve as your digestive system acclimates to the slower gastric emptying semaglutide creates. Increasing fiber intake gradually, drinking plenty of water, and maintaining light physical activity help counteract constipation naturally. If side effects become bothersome or persistent, your PlexusDx-connected provider can extend the time between dose increases or explore alternative formulations like oral semaglutide or the Microdose GLP-1 Protocol to match your tolerance profile.

Personalization and Genetic Testing for Your Semaglutide Plan

Not everyone responds identically to semaglutide because genetic variation in GLP-1 receptor sensitivity and related metabolic pathways influences how effectively the medication works for each individual. PlexusDx's Precision Peptide Genetic Test examines key genetic variants—including GLP1R rs6923761, GIPR rs1800437, FTO rs9939609, and MC4R rs17782313—that predict your peptide-pathway response and help fine-tune your treatment protocol. This $99 add-on test, taken after your first month of treatment, maps 14 biological pathways and 49 peptides to identify which dosing strategy and medication formulation aligns best with your genetic predispositions.

Patients with certain GLP1R variants may reach therapeutic benefit at lower doses, while others may need higher maintenance levels for optimal satiety signaling and weight loss. Understanding your genetic profile allows your provider to personalize your weekly injection schedule, adjust escalation timing, and select between semaglutide injection, oral semaglutide, tirzepatide, or dual-compound options like GLP-Squared to match your unique metabolism. This precision approach reduces trial-and-error dosing and increases the likelihood of sustained weight management success over months and years.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Can I skip a week of my semaglutide injection without losing progress?

Skipping a single weekly injection may not eliminate your progress immediately, but it disrupts the consistent medication levels your body relies on for appetite suppression and metabolic benefits. If you miss a dose, take it as soon as you remember unless your next scheduled injection is within 2 days; in that case, skip the missed dose and resume your normal weekly schedule. Maintaining a consistent once-weekly routine is essential for maximizing weight loss and avoiding the return of hunger and cravings.

How much weight can you expect to lose with weekly semaglutide injections?

Clinical trials show that patients on semaglutide typically lose 5% to 15% of their baseline body weight over 68 weeks, with some individuals achieving 20% or greater reductions when combined with lifestyle changes like reduced calorie intake and regular movement. Individual results vary significantly based on genetics, adherence, diet quality, and exercise habits; this is why PlexusDx offers the Precision Peptide Genetic Test to identify how your body is likely to respond before committing to a specific protocol.

What is the cost of weekly semaglutide injections at PlexusDx?

PlexusDx offers compounded semaglutide injections from licensed 503A compounding pharmacies starting at $149 per month, with flat pricing across all dose levels—meaning your cost remains the same whether you are in week one at 0.25 mg or at maintenance at 1.0 mg or higher. PlexusDx serves all 50 states without requiring insurance or a membership fee, and all medications are HSA and FSA eligible for additional savings. This transparent, dose-independent pricing removes financial barriers to reaching your full therapeutic dose over your 16- to 20-week escalation schedule.

Is compounded semaglutide as safe as the brand-name Wegovy® injection?

Compounded semaglutide from licensed 503A compounding pharmacies undergoes rigorous quality and sterility testing to meet pharmaceutical standards, and the active ingredient (semaglutide) is identical to brand-name formulations. The main difference is that compounded versions are prepared by licensed pharmacies rather than manufactured by a pharmaceutical company; this allows for personalized dosing, lower cost, and faster access without insurance delays.

How does the Precision Peptide Genetic Test improve my semaglutide injection plan?

The PlexusDx Precision Peptide Genetic Test identifies your genetic predispositions across 14 metabolic pathways and 49 peptides involved in appetite regulation, glucose control, and fat storage, allowing your provider to personalize your weekly injection schedule and select the optimal medication form. Testing reveals whether you are likely to have high GLP-1 receptor sensitivity (potentially reaching your goal at lower doses) or reduced sensitivity (possibly benefiting from higher doses or dual-compound therapies like GLP-Squared).

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves